Meghan Stoppel will be a panelist at a discussion titled “Analyzing New State Laws and Legislation Affecting Supplements: Considerations for Interstate Compliance and What Recent State Activity Could Mean for Future of FDA Deference.” The panel will examine newly introduced and proposed state bills placing age restrictions on the purchase of certain supplements products.
To learn more and register for this event, click here.